Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

The Lancet

Volumn 346, Issue 8977, 1995, Pages 732-736

  Kiowski, W ^a   Kim, J ^a   Oechslin, E ^a   Sütsch, G ^a   Hunziker, P ^b   Müller, P ^b   Bertel, O ^b   Schmitt, R ^c   Jones, R ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Triemli Hospital Zurich ^*  (Netherlands)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; NITRATE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD VESSEL TONE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE FILLING PRESSURE; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0029087262     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91504-4     Document Type: Article

References (30)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
3. Regulatory functions of the endothelium
4. Formation by the endothelium of prostacyclin nitric oxide and endothelin
5. Endothelin has biological actions at pathophysiological concentrations
6. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist
7. Antihypertensive effects of the endothelin receptor antagonist BQ-123 in conscious spontaneously hypertensive rats
8. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure
9. Contribution of endogenous generation of endothelin-1 to basal vascular tone
10. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure
11. Endothelin in human congestive heart failure
12. Arterial vasodilator, systemic and coronary haemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy
13. Radioimmunological determination of endothelin peptides in human plasma a methodological approach
14. Measurement for angiotensin II in human plasma technical modifications and practical experience
15. Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain
16. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension
17. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing faxtor
18. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels
19. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogeneously administered endothelin-1 in clinically healthy smokers
20. Clearance of circulating endothelin-1 by ETB receptors in rats
21. Results of long-term vasodilator therapy in patients with refractory congestive heart failure
22. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure
23. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure
24. Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle
25. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
26. Arterial baroreflex abnormalities in heart failure. Reversal after orthotopic cardiac transplantation
27. Effects on feline pial arterioles in situ of bosentan, a non-peptide endothelin receptor antagonist
28. Naloxone augments sympathetic outflow induced by centrally administered endothelin in conscious rabbits
29. Sensitization of baroreceptor reflex by central endothelin in conscious rats
30. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers